Jiangsu Aidea Pharmaceutical Group Co Ltd. Stock Analysis 688488.SS

Jiangsu Aidea Pharmaceutical Group Co., Ltd. produces and sells human protein products, and carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents. The company is headquartered in Yangzhou, Jiangsu and currently employs 735 full-time employees. The company went IPO on 2020-07-20. The firm is also engaged in the business of HIV diagnostic equipment and reagents. The firm's human protein products mainly include crude ulinastatin, crude urokinase and crude urokinase. The Company’s drugs include products Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, Ainuovirine Tablets, Sennae Folium Granules and Live Bacillus Cereus Tablets. The firm mainly distributes its products within the domestic market.